LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - Immunovant (NASDAQ: IMVT)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ IMVT Immunovant
Van Tuyl Christopher / officer: Chief Legal Officer
12/18/2025
Sell
$26.78
8,529
$228K
152,214
NASDAQ IMVT Immunovant
Van Tuyl Christopher / officer: Chief Legal Officer
12/18/2025
Sell
$27.38
2,284
$63K
149,930
NASDAQ IMVT Immunovant
Roivant Sciences Ltd. / director, 10 percent owner:
12/12/2025
Buy
$21.00
16.67M
$350.000M
113.32M
NASDAQ IMVT Immunovant
Fromkin Andrew J. / director
12/01/2025
Sell
$23.14
19,351
$448K
88,750
NASDAQ IMVT Immunovant
Fromkin Andrew J. / director
12/01/2025
Sell
$23.95
2,898
$69K
85,852
NASDAQ IMVT Immunovant
Hughes Douglas J. / director
12/01/2025
Sell
$23.14
13,091
$303K
122,682
NASDAQ IMVT Immunovant
Hughes Douglas J. / director
12/01/2025
Sell
$23.96
1,909
$46K
120,773
NASDAQ IMVT Immunovant
Gloria Melanie / officer: Chief Operating Officer
11/20/2025
Sell
$23.54
10,251
$241K
175,886
NASDAQ IMVT Immunovant
Gloria Melanie / officer: Chief Operating Officer
11/20/2025
Sell
$23.97
2,375
$57K
173,511